4.8 Article

A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress

Journal

SCIENCE
Volume 307, Issue 5711, Pages 935-939

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1101902

Keywords

-

Funding

  1. NIAID NIH HHS [AI19838, AI26077] Funding Source: Medline
  2. NIA NIH HHS [R37-AG012859] Funding Source: Medline
  3. NIDDK NIH HHS [DDK42394, DK47119] Funding Source: Medline
  4. NIEHS NIH HHS [ES08681] Funding Source: Medline
  5. NIGMS NIH HHS [GM64703] Funding Source: Medline
  6. NINDS NIH HHS [NS35138] Funding Source: Medline

Ask authors/readers for more resources

Most protein phosphatases have little intrinsic substrate specificity, making selective pharmacological inhibition of specific dephosphorylation reactions a challenging problem. In a screen for small molecules that protect cells from endoplasmic reticulum (ER) stress, we,identified salubrinal, a selective inhibitor of cellular complexes that dephosphorylate eukaryotic translation initiation factor 2 subunit alpha (eIF2alpha). Salubrinal also blocks eIF2alpha dephosphorylation mediated by a herpes simplex virus protein and inhibits viral replication. These results suggest that selective chemical inhibitors of eIF2a dephosphorylation may be useful in diseases involving ER stress or viral infection. More broadly, salubrinal demonstrates the feasibility of selective pharmacological targeting of cellular dephosphorylation events.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available